Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
US11173132B2 · kind B2 · utility
2Cited by
64References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2018 |
| Grant date | Nov 16, 2021 |
| Priority date | — |
| Expiry date | Mar 14, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods, compositions, and devices for transdermally administering an active agent such as memantine are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.